Summary
Arg-Pro-Pro-Gly-Phe, the N-terminal pentapeptide of bradykinin, is not an inhibitor of angiotensin-converting enzyme and is not hydrolyzed by the enzyme. Arg-Pro-Pro, the N-terminal tripeptide is a relatively potent (IC50=2.3×106 M) inhibitor but its higher homolog, Gly-Arg-Met-Lys-Arg-Pro-Pro is not an inhibitor of angiotensin-converting enzyme.
Article PDF
Similar content being viewed by others
Literatur
F.E. Dorer, J.R. Kahn, K.E. Lentz, M. Levine and L.T. Skeggs, Circulation Res.34, 824 (1974).
R.L. Soffer, R. Reza and P.R.B. Caldwell, Proc. nat. Acad. Sci. USA17, 1720 (1974).
D.R. Borges, E.A. Limaos, J.L. Prado and A.C.M. Camargo, Naunyn-Schmiedeberg's Arch. Pharmac.295, 33 (1976).
G. Oshima and E.G. Erdos, Experientia30, 733 (1974).
F.E. Dorer, J.R. Kahn, K.E. Lentz, M. Levine and L.T. Skeggs, Biochim. biophys. Acta429, 220 (1976).
F.E. Dorer, J.R. Kahn, K.E. Lentz, M. Levine and L.T. Skeggs, Circulation Res.31, 356 (1972).
J.M. Stewart and J.D. Young, Solid Phase Peptide Synthesis. W. H. Freeman, San Francisco 1969.
R. Igic, E.G. Erdos, H.S.J. Yeh, K. Sorrells and T. Nakajima, Circulation Res.31 suppl. 2, 51 (1972).
Author information
Authors and Affiliations
Additional information
This work was supported in part by grants from the US Public Health Service (HL 18415, HL 15691, HL 19764) and the John A. Hartford Foundation, Inc., and by the Medical Research Service of the Veterans Administration.
Rights and permissions
About this article
Cite this article
Dorer, F.E., Stewart, J.M. & Ryan, J.W. Studies on the hydrolysis of bradykinin by angiotensin-converting enzyme (kininase II). Experientia 34, 1436 (1978). https://doi.org/10.1007/BF01932334
Published:
Issue Date:
DOI: https://doi.org/10.1007/BF01932334